Hélène Eltchaninoff CHU Rouen, France Symposium Edwards Valves Aortiques Hightech 2012 - MARSEILLE Le futur.

Slides:

Advertisements

Similar presentations

Jeffrey W. Moses, MD Columbia University Medical Center Cardiovascular Research Foundation New York City The State of TAVR -PARTNER: From Concept to Mortality.

Advertisements

” سبحانك لا علم لنا إلا ما علمتنا إنك أنت العليم الحكيم “

Marie Erpicum – Perfusionniste Département de chirurgie cardiovasculaire et thoracique - CHU de Liège Marie Erpicum Perfusionnist Cardiovascular & Thoracic.

Trans-catheter Aortic Valve Implantation Should we all be doing this? Dr Philip MacCarthy BSc PhD FRCP Consultant Cardiologist King’s College Hospital,

Pinhas (Peter) Dartal 01 June QA role in development of Percutaneous Aortic Valve prosthesis.

INTERNATIONAL CAUTION: For distribution only in markets where Engager has been approved. Not approved in the USA, Canada, or Japan. Medtronic Engager Transcatheter.

Hospital Israelita Albert Einstein São Paulo São Paulo SBHCI 2010 Belo Horizonte, MG; July 23, 2010 Update on TAVI Studies: Edwards SAPIEN® Transcatheter.

THE USE OF A TRANSCATHETER AORTIC VALVE TO REPLACE A DEFECTIVE AORTIC VALVE WITHOUT OPEN-HEART SURGERY Natalie Garda and Adam Cotter Heart disease is the.

Lessons from TAVR Randomized Trials and Registries E Murat Tuzcu, MD Professor of Medicine Cleveland Clinic Financial disclosures: None PARTNER Executive.

TAVR. Global and US Data. Pichard,

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC.

Dr Martyn Thomas Director of Cardiac Services Guys and St Thomas NHS Foundation Trust A Member of Kings Health Partners London.

Endovaskuläre Therapie von Aortenklappenpathologien

Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.

Utilizing Science & Technology and Innovation for Development Transcatheter Therapies For Congenital & Structural Heart Disease Marriott Hotel- Amman,

A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

TCT 2015 | San Francisco | October 15, 2015 Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses Danny Dvir, MD John G. Webb, MD and.

Alan Zajarias Assistant Professor of Medicine

EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Aortic Valve Replacement Will Become.

TAVR for the Treatment of Pure Native Aortic Valve Regurgitation

PERCUTANEOUS PULMONARY VALVE REPLACEMENT:

A: The Edward SAPIEN balloon expandable valve (Edwards Lifesciences, Irvine, CA) incorporates a stainless steel frame, bovine pericardial leaflets, and.

Late breaking news in heart valve disease

The Medtronic Ventor EngagerTM TAVI System

Is Transoesophageal Echocardiography during TAVR Essential?

The Lotus Device Design & FIM Experiences with a Repositionable Self Expanding Percutaneous Aortic Valve Ian T. Meredith MBBS, BSc(Hons), Ph.D, FRACP,

TAVR in 2017 Past, Present and Future

Relation of aortic regurgitation to all-cause mortality in the transcatheter aortic valve replacement (TAVR) as-treated population of the Placement of.

Design & Product Development Larry L Wood

Direct Flow Medical Experience with a Conformable, Repositionable, Retrievable, Percutaneous Aortic Valve Reginald Low MD University of California,Davis.

Potential conflicts of interest

Ganesh Manoharan Consultant Cardiologist

EVOLUT R, Next Generation, and Future

TAVR-Endocarditis Tarek Chami, MD

TAVR: How We continue to Refine the Technology and Improve the Results

Portico™ Transcatheter Aortic Valve Replacement Program CRT 2013

Review of the Latest OUS Data from the Self-Expanding Valve Studies

Copyright © 2014 American Medical Association. All rights reserved.

30 Day Outcomes from the SOURCE XT TAVI Post Approval Study

Echo Essentials for TAVI

Jodi J. Akin, MS VP Global Clinical Affairs,

Direct Flow Medical Experience with a Conformable, Repositionable Retrievable Percutaneous Aortic Valve Reginald Low MD University of California, Davis.

Opportunities to Study Valve Iterations and Modifications in the US

Rush University Medical Center, Chicago, IL

Technology Update and Status of Current Clinical Trials

Ganesh Manoharan Consultant Cardiologist

Second Generation Valves: What Will Be Different?

TAVR: Similarities and Differences in the US and Japan

Balloon-Expandable Transcatheter Valve System : OUS Data

Keith B. Allen, MD, Adnan K. Chhatriwalla, MD, David J

Nat. Rev. Cardiol. doi: /nrcardio

Transcatheter Aortic Valve Replacement

Figure 4 Valve-in-valve implantations in degenerated surgical valves

Figure 1 Types of surgical and transcatheter aortic valves

Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years Jian Ye, MD, FRCSC, John G. Webb, MD,

Open transcatheter tricuspid balloon expandable valve-in-valve implantation for failed bioprosthesis Gino Gerosa, MD, Augusto D'Onofrio, MD, Chiara Tessari,

Michael J. Davidson, MD, Frederick G. P. Welt, MD, Andrew C

Stent and Leaflet Stresses in 29-mm Second-Generation Balloon-Expandable Transcatheter Aortic Valve Yue Xuan, PhD, Kapil Krishnan, PhD, Jian Ye, MD,

A.A. Klein, S.T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, C. Densem

Pranav Loyalka, MD, Kelsey B. Montgomery, BS, Tom C

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.

Moritz Seiffert et al. JCIN 2012;5:

Stent and leaflet stresses in a 26-mm first-generation balloon-expandable transcatheter aortic valve Yue Xuan, PhD, Kapil Krishnan, PhD, Jian Ye, MD,

The transapical approach for aortic valve implantation

Renuka Jain, MD, Mohamed F. Algahim, MD, Tanvir K. Bajwa, MD, Bijoy K

Mackram F. Eleid et al. JIMG 2016;9:

Transcatheter aortic valve implantation: The European experience

Nat. Rev. Cardiol. doi: /nrcardio

Presentation transcript:

Hélène Eltchaninoff CHU Rouen, France Symposium Edwards Valves Aortiques Hightech MARSEILLE Le futur

Nouvelle technologie Etudes

20mm* SAPIEN XT, disponible en 4 tailles SAPIEN XT THV* Hors USA Voies Transapicale et Transaortique Voie Transfémorale NovaFlex+ with eSheath Ascendra+* Annulus Size (mm) 23mm 26mm 29mm* Tailles 12/9/2011 Japan EU

…Expect CE Mark Trials on Two New Valve Platforms in /9/2011 Balloon-Expandable

…Expect CE Mark Trials on Two New Valve Platforms in /9/2011 Balloon Expandable Self-Expanding Balloon-Expandable

Edwards SAPIEN 3 Valve Ultra Low-Profile Balloon Expandable Platform SAPIEN 3 Valve Designed to further reduce PV leaks Lower profile valve : 14 Fr eSheath Discrete valve that anchors in the annulus Treated bovine pericardial tissue leaflets Dramatically reduced profile for the transapical approach 12/9/2011

Edwards CENTERA Valve CENTERA is Edwards’ First Self- Expanding Transcatheter Valve Motorized delivery system for stable deployment and single operator use Repositionable Delivered through a 14 Fr eSheath Discrete valve that anchors in the annulus Treated bovine pericardial tissue leaflets Transfemoral and subclavian approach 12/9/2011 Ultra Low-Profile Self Expanding Platform First-in-Man Experience Completed

Les études en cours et à venir PARTNER 2: Critère combiné décès + AVC 1) SAPIEN XT vs RVA STS < 4% 2) SAPIEN vs SAPIEN XT Pts inopérables USA PROTAVI-C: AVC et IRM (Embrella)